Skip to main content
. Author manuscript; available in PMC: 2012 Jul 26.
Published in final edited form as: Innov Pharm. 2012;3(2):1–11. doi: 10.24926/iip.v3i2.257

Table 3.

Demographic, seasonal influenza vaccine history, and HBM attitudinal variables associated with intention to receive the novel H1N1 influenza vaccine

Likelihood of Intention to Receive Vaccine (n = 360)a,b

Items OR [95% CI] p-value
Demographics

Age (n=620) 0.12
 < 25 years 0.27 [0.08 – 0.93] 0.04
 25 – 64 years 1.0
 ≥ 65 years 1.00 [0.37 – 2.74] 0.99

Gender (n=657)
 Male 1.0
 Female 1.51[0.84 – 2.71] 0.17

Race/Ethnicity (n=632)
 Caucasian 1.0
 Non-Caucasian 1.26 [0.66 – 2.41] 0.48

Estimated Annual Income (n=597) 0.20
 Less than $10,000 4.38 [1.21 – 15.83] 0.02
 $10,001 to $25,000 1.12 [0.46 – 2.75] 0.80
 $25,001 to $40,000 1.0
 $40,001 to $55,000 0.95 [0.40 – 2.27] 0.91
 More than $55,000 0.95 [0.47 – 1.91] 0.88

Highest Education Level (n=647) 0.06
 Some high school 0.27 [0.07 – 1.12] 0.07
 High school or GED 1.0
 Some college 0.44 [0.22 – 0.92] 0.03
 Undergraduate degree 0.40 [0.17 – 0.91] 0.03
 Graduate/professional degree 0.86 [0.34 – 2.18] 0.74

Member of High Risk Group (n=664)
 Yes 1.0
 No 0.85 [0.45 – 1.62] 0.63

VCU student (n=664)
 Yes 1.0
 No 1.03 [0.31 – 3.43] 0.96

Seasonal Influenza Vaccine History

History of a past seasonal influenza vaccine (n=652)
 Yes 1.0
 No 0.64 [0.32 – 1.27] 0.20

History of a seasonal influenza vaccine last year (2008) (n=651)
 Yes 1.0
 No 0.45 [0.24 – 0.83] 0.01

Health Belief Model Domains

Perceived Severity of the Virus (n=637) 1.24 [0.83 – 1.85] 0.30
If I get the novel H1N1 influenza virus I will get sick.
If I get the novel H1N1 influenza virus I will lose income.
If I get the novel H1N1 influenza virus other members in my home will get sick.
If I get the novel H1N1 influenza virus I will die.

Perceived Susceptibility to the Virus (n=656) 1.03 [0.68 – 1.54] 0.90
I am at risk for getting the novel H1N1 influenza virus.
My family members are at risk for getting the novel H1N1 influenza virus.
I feel knowledgeable about my risk of getting the novel H1N1 influenza virus.

Perceived Clinical Barriers to Vaccination (n=640) 0.57 [0.35 – 0.93] 0.02
I will have side effects from the novel H1N1 influenza vaccine.
I will get sick from the novel H1N1 influenza vaccine.
I will die from the novel H1N1 influenza vaccine.
The novel H1N1 influenza vaccine will be painful.

Perceived Access Barriers to Vaccination
The novel H1N1 influenza vaccine will be expensive. (n=653) 1.07 [0.77 – 1.50] 0.68
It is inconvenient to get the novel H1N1 influenza vaccine. (n=657) 0.94 [0.74 – 1.19] 0.62
There is a shortage of the novel H1N1 influenza vaccine. (n=648) 0.89 [0.67 – 1.19] 0.44

Perceived Specific Vaccine Benefit
If I receive the novel H1N1 influenza vaccine, I will not get sick from the novel H1N1 influenza virus. (n=653) 1.25 [0.92 – 1.70] 0.16

Perceived General Vaccine Benefits (n=658) 1.42 [0.97 – 2.06] 0.07
Vaccines prevent disease.
Vaccines are safe.

Virus Information Sources (n=664) 0.92 [0.76 – 1.12] 0.42

Vaccine Information Sources (n=664) 1.15 [0.94 – 1.40] 0.17

Physician Recommendation (n=556)
 Yes 1.0
 No 0.26 [0.11 – 0.62] 0.002

Pharmacist Recommendation (n=546)
 Yes 1.0
 No 0.90 [0.39 – 2.05] 0.80

Nurse Recommendation (n=548)
 Yes 1.0
 No 0.84 [0.31 – 2.26] 0.73
a

n = 360 due to missing responses

b

Likelihood ratio for the model intention to receive vaccine; χ2 = 111.22, p < 0.0001.